We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Immune Chemokines Biomarkers Explored for Pediatric Tuberculosis Diagnosis

By LabMedica International staff writers
Posted on 03 Nov 2021
Print article
Image: The Luminex Magpix multiplex cytokine assay system (Photo courtesy of Bio-Rad)
Image: The Luminex Magpix multiplex cytokine assay system (Photo courtesy of Bio-Rad)
Diagnosis of active tuberculosis (TB) in children provides a key challenge, because most of the clinical symptoms of TB in children are non-specific with signs and symptoms that resemble common pediatric illnesses, including pneumonia and malnutrition and therefore clinical diagnosis is unreliable.

Better-quality methods for diagnosing pediatric TB are thus immediately needed and immunological biomarker assays can bring light to this problem. Chemokines are chemoattractant molecules that control immunological responses and have been widely considered for their utility as diagnostic biomarkers of adult TB.

Tuberculosis Specialists at the ICMR-National Institute for Research in Tuberculosis (Chennai, India) conducted a prospective case control study using children with confirmed, unconfirmed and unlikely TB. Of the 195 children screened, 167 children were recruited which includes 44 children who were microbiology positive (confirmed TB) for Mycobacterium tuberculosis (M.tb), 47 children who were microbiology negative (unconfirmed TB), 76 children with other respiratory ailments with tuberculin skin Test (TST) positive or negative as unlikely TB controls. Confirmed TB defined as microbiologically positive for M.tb., positive for Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) or smear or culture for M.tb.

Plasma levels of CC (CCL1, CCL2, CCL3, CCL4 and CCL11) and CXC (CXCL1 CXCL2, CXCL9, CXCL10 and CXCL11) chemokines were measured using the Luminex Magpix multiplex cytokine assay system (Bio-Rad, Hercules, CA, USA). Luminex Human Chemokine Magnetic Assay kit (R&D Systems, Minneapolis, MN, USA) was used to measure the chemokine levels.

The investigators reported that baseline levels of CCL1, CCL3, CXCL1, CXCL2 and CXCL10 were significantly higher in active TB (confirmed TB and unconfirmed TB) in comparison to unlikely TB children. Receiver operating characteristics curve analysis revealed that CCL1, CXCL1 and CXCL10 could act as biomarkers distinguishing confirmed or unconfirmed TB from unlikely TB with the sensitivity and specificity of more than 80%. In addition, computation and selection of optimal biomarker combinations by integrative ROC were analyzed (CombiROC, Milan, Italy) and exhibited more than 90% sensitivity and specificity in distinguishing confirmed and unconfirmed TB from unlikely TB. Finally, classification and regression tree models also offered more than 90% sensitivity and specificity for CCL1 with a cutoff value of 28 pg/mL, which clearly classify active TB from unlikely TB.

The authors concluded that baseline chemokine signature of CCL1/CXCL1/CXCL10 could serve as an accurate biomarker for the diagnosis of pediatric tuberculosis. The study was published on October 11, 2021 in the journal BMC Infectious Diseases.

Related Links:
ICMR-National Institute for Research in Tuberculosis
Cepheid
Bio-Rad
R&D Systems
CombiROC


Gold Supplier
SARS-CoV-2 Multiplex Real-Time RT-PCR Assay
GSD NovaPrime Plus SARS-CoV-2
New
Tuberculosis (TB) Test
QIAreach QuantiFERON-TB
New
SARS-CoV-2 Antigen Immunofluorescence System
Watmind SARS-CoV-2 Antigen Immunofluorescence System
New
Gold Supplier
Centrifuge
Multifuge X4 Pro Centrifuge Series

Print article

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.